Showing results (141-150 of 218) with videos related to
Sort By:
Pageof 22
Annals of the Rheumatic Diseases|February 5, 2015
IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritisAmy E Anderson, Arthur G Pratt, Mamdouh A K Sedhom, et al.The Journal of Allergy and Clinical Immunology|January 17, 2020
Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease lociAlexander D Clark, Nisha Nair, Amy E Anderson, et al.Drug Safety|June 11, 2016
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and PsoriasisMegan E B Clowse, Steven R Feldman, John D Isaacs, et al.Medicine|June 27, 2020
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trialStefan Siebert, Arthur G Pratt, Deborah D Stocken, et al.Rheumatology (Oxford, England)|April 4, 2022
Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapyMegan Sutcliffe, Nisha Nair, James Oliver, et al.Human Mutation|February 1, 2012
Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritisJames I Robinson, Ian M Carr, Dawn L Cooper, et al.The Lancet. Rheumatology|October 18, 2025
Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine studyJoshua L Bennett, Kieren G Hollingsworth, Arthur G Pratt, et al.Annals of Internal Medicine|September 13, 2013
Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trialJoel Kremer, Zhan-Guo Li, Stephen Hall, et al.Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.Journal of Translational Medicine|November 16, 2019
Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritisRachel Spiering, Manon A A Jansen, Matthew J Wood, et al.Pageof 22